首页> 外国专利> COMPOSITIONS COMPRISING EMBRYONIC-LIKE STEM CELLS DERIVED FROM POST-PARTUM MAMMALIAN PLACENTA AND HUMAN STEM OR PROGENITOR CELLS AND KITS COMPRISING SUCH COMPOSITIONS

COMPOSITIONS COMPRISING EMBRYONIC-LIKE STEM CELLS DERIVED FROM POST-PARTUM MAMMALIAN PLACENTA AND HUMAN STEM OR PROGENITOR CELLS AND KITS COMPRISING SUCH COMPOSITIONS

机译:包含源自产后哺乳动物疟原虫的胚胎干细胞和人类干细胞或祖细胞以及包含此类成分的试剂盒的组合物

摘要

The present invention provides compositions and methods of using embryonic-like stem cells that originate from a post-partum placenta with conventional cord blood compositions or other stem or progenitor cells. The embryonic-like stem cells can be used alone or in a mixture with other stem cell populations. In accordance with the present invention, the embryonic-like stem cells may be mixed with other stem cell populations, including but not limited to, umbilical cord blood, fetal and neonatal hematopoietic stem cells and progenitor cells, human stem cells and progenitor cells derived from bone marrow. The embryonic-like stem cells and the mixed populations of embryonic-like stem cells and stem cells have a multitude of uses and applications, including but not limited to, therapeutic uses for transplantation and treatment and prevention of disease, and diagnostic and research uses.
机译:本发明提供了使用来源于产后胎盘的胚胎样干细胞与常规脐带血组合物或其他干细胞或祖细胞一起使用的组合物和方法。胚胎样干细胞可单独使用或与其他干细胞群混合使用。根据本发明,可以将胚胎样干细胞与其他干细胞群体混合,包括但不限于脐带血,胎儿和新生儿造血干细胞和祖细胞,人干细胞和源自祖细胞的祖细胞。骨髓。胚胎样干细胞以及胚胎样干细胞和干细胞的混合群体具有多种用途和应用,包括但不限于用于移植,治疗和预防疾病的治疗用途以及诊断和研究用途。

著录项

  • 公开/公告号IL163439A

    专利类型

  • 公开/公告日2011-03-31

    原文格式PDF

  • 申请/专利权人 ANTHROGENESIS CORPORATION;

    申请/专利号IL20040163439

  • 发明设计人

    申请日2004-08-10

  • 分类号A61K35/12;A61K35/28;A61K35/48;A61P3/10;A61P9;A61P9/10;A61P17/02;A61P19;A61P21;A61P25;A61P25/02;A61P25/28;A61P29;A61P37/06;C12N5/02;C12N5/073;C12N5/074;

  • 国家 IL

  • 入库时间 2022-08-21 18:06:23

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号